Ben Bruno

Ben Bruno has a diverse work experience in the fields of clinical development, scientific affairs, academia, and pharmacy. Their most recent role is as a Senior Director of Clinical Development at Lipocine Inc. Ben previously held positions as a Director and Manager of Clinical Development at the same company. Ben also worked as an Adjunct Professor at the University of Utah and Utah Valley University, where they taught courses related to genetic techniques, bioethics, and CRISPR technology. Ben has experience in scientific affairs as a Scientific Affairs Manager at NAVICAN, where they represented the company's scientific expertise and coordinated strategies with key stakeholders. Prior to that, Ben worked as a Clinical Trial Specialist at the Sports Medicine Research and Testing Lab. Ben also has a background in research, having worked as a Graduate Student at the University of Utah, where they focused on developing a delivery strategy for a novel gene/protein for the treatment of Chronic Myelogenous Leukemia (CML). Additionally, Ben gained practical experience as a Pharmacy Intern at University Pharmacy.

Ben Bruno earned a Bachelor's degree in Biology from the University of Michigan in 2009. Afterwards, they attended the University of Utah, where they obtained a Doctor of Pharmacy degree in 2013. Ben continued their education at the University of Utah and completed a Doctor of Philosophy (PhD) in Pharmaceutical Sciences in 2017. In May 2018, they obtained a certification as a Pharmacist from the Utah Division of Occupational and Professional Licensing.